1. |
何林烨, 王艺超, 李志辉. 2022年中国甲状腺癌流行情况分析: 基于《中国肿瘤登记年报》2005–2018年数据. 中国普外基础与临床杂志, 2024, 31(7): 790-795.
|
2. |
Han B, Zheng R, Zeng H, et al. Cancer incidence and mortality in China, 2022. J Natl Cancer Cent, 2024, 4(1): 47-53.
|
3. |
Malaguarnera R, Vella V, Pellegriti G, et al. Editorial: Clinical and molecular epidemiology of thyroid cancer of follicular origin. Front Endocrinol (Lausanne), 2018, 9: 67. doi: 10.3389/fendo.2018.00067.
|
4. |
吕恬, 王佳峰, 徐加杰, 等. 《中国肿瘤整合诊治指南—CACA甲状腺癌诊治指南》外科部分解读. 中国普外基础与临床杂志, 2023, 30(2): 154-159.
|
5. |
Sui C, Liang N, Du R, et al. Time trend analysis of thyroid cancer surgery in China: single institutional database analysis of 15 000 patients. Endocrine, 2020, 68(3): 617-628.
|
6. |
Boucai L, Zafereo M, Cabanillas M E. Thyroid cancer: A review. JAMA, 2024, 331(5): 425-435.
|
7. |
凡中霞, 王永波. 甲状腺癌患者术后特异性生活质量的现状及其影响因素分析. 中国普外基础与临床杂志, 2024, 31(7): 840-847.
|
8. |
田文, 刘军言. 中国甲状腺外科近十年成就. 西安交通大学学报(医学版), 2024, 45(1): 1-8.
|
9. |
中华医学会内分泌学分会, 中华医学会外科学分会甲状腺及代谢外科学组, 中国抗癌协会头颈肿瘤专业委员会, 等. 甲状腺结节和分化型甲状腺癌诊治指南(第二版). 中华内分泌代谢杂志, 2023, 39(3): 181-226.
|
10. |
Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid cancer. Thyroid, 2016, 26(1): 1-133.
|
11. |
郑传铭, 徐加杰, 蒋烈浩, 等. 无充气腋窝入路完全腔镜下甲状腺叶切除的方法—葛-郑氏七步法. 中国普通外科杂志, 2019, 28(11): 1336-1341.
|
12. |
Jung CK, Bychkov A, Kakudo K. Update from the 2022 World Health Organization Classification of Thyroid Tumors: A Standardized Diagnostic Approach. Endocrinol Metab (Seoul), 2022, 37(5): 703-718.
|
13. |
Tuttle RM, Haugen B, Perrier ND. Updated American Joint Committee on cancer/tumor-node-metastasis staging system for differentiated and anaplastic thyroid cancer (Eighth Edition): What changed and why?. Thyroid, 2017, 27(6): 751-756.
|
14. |
姚承志, 张敏, 曾雨可, 等. 中国甲状腺癌发病和死亡趋势分析与预测. 中华流行病学杂志, 2023, 44(6): 917-923.
|
15. |
Schlumberger M, Hitzel A, Toubert ME, et al. Comparison of seven serum thyroglobulin assays in the follow-up of papillary and follicular thyroid cancer patients. J Clin Endocrinol Metab, 2007, 92(7): 2487-2495.
|
16. |
Leboulleux S, Girard E, Rose M, et al. Ultrasound criteria of malignancy for cervical lymph nodes in patients followed up for differentiated thyroid cancer. J Clin Endocrinol Metab, 2007, 92(9): 3590-3594.
|
17. |
Frasoldati A, Pesenti M, Gallo M, et al. Diagnosis of neck recurrences in patients with differentiated thyroid carcinoma. Cancer, 2003, 97(1): 90-96.
|
18. |
Brown BC, McKenna SP, Siddhi K, et al. The hidden cost of skin scars: quality of life after skin scarring. J Plast Reconstr Aesthet Surg, 2008, 61(9): 1049-1058.
|
19. |
徐加杰, 张李卓, 张启弘, 等. 无充气经腋窝腔镜甲状腺手术的临床应用. 中华耳鼻咽喉头颈外科杂志, 2020, 55(10): 913-920.
|
20. |
陈孝磊, 李超, 周雨秋, 等. 经腋无充气腔镜与传统颈部开放手术治疗PTC的疗效分析. 中华耳鼻咽喉头颈外科杂志, 2023, 58(4): 351-357.
|
21. |
Qu Y, Han Y, Wang W, et al. Clinical analysis of total endoscopic thyroidectomy via breast areola approach in early differentiated thyroid cancer. J BUON, 2021, 26(3): 1022-1027.
|
22. |
来益, 沈宇玲, 王家东. 不同入路腔镜甲状腺手术和传统开放甲状腺手术疗效分析. 中国眼耳鼻喉科杂志, 2023, 23(1): 34-38.
|
23. |
郭湃, 张浩, 张云生, 等. 腋窝入路无充气腔镜手术与开放性甲状腺癌根治术对甲状腺癌患者颈部功能的影响分析. 中国实用医药, 2024, 19(4): 53-56.
|
24. |
孙思雨, 张晨嵩, 谢波, 等. 经腋窝入路免充气全腔镜甲状腺癌根治术和开放甲状腺癌根治术疗效对比. 蚌埠医学院学报, 2021, 46(2): 173-175, 178.
|
25. |
Jeong JJ, Kang SW, Yun JS, et al. Comparative study of endoscopic thyroidectomy versus conventional open thyroidectomy in papillary thyroid microcarcinoma (PTMC) patients. J Surg Oncol, 2009, 100(6): 477-480.
|
26. |
Kang SW, Jeong JJ, Yun JS, et al. Gasless endoscopic thyroidectomy using trans-axillary approach; surgical outcome of 581 patients. Endocr J, 2009, 56(3): 361-369.
|
27. |
渠宁, 王钰婷, 马奔, 等. 2022年度甲状腺癌研究及诊疗新进展. 中国癌症杂志, 2023, 33(5): 423-430.
|
28. |
周余, 程若川, 李想. 合并桥本氏甲状腺炎对甲状腺乳头状癌临床侵袭性影响的回顾性分析. 中华内分泌外科杂志, 2022, 16(1): 41-44.
|
29. |
丁科, 黄江生, 汪明明, 等. 腔镜与开放手术治疗低危型甲状腺乳头状癌的疗效比较: 附538例报告. 中国普通外科杂志, 2019, 28(5): 524-531.
|
30. |
Jiang WJ, Yan PJ, Zhao CL, et al. Comparison of total endoscopic thyroidectomy with conventional open thyroidectomy for treatment of papillary thyroid cancer: a systematic review and meta-analysis. Surg Endosc, 2020, 34(5): 1891-1903.
|
31. |
Zhang X, Li JG, Zhang SZ, et al. Comparison of indocyanine green and carbon nanoparticles in endoscopic techniques for central lymph nodes dissection in patients with papillary thyroid cancer. Surg Endosc, 2020, 34(12): 5354-5359.
|
32. |
Chen S, Hou X, Hua S, et al. Mitoxantrone hydrochloride injection for tracing helps to decrease parathyroid gland resection and increase lymph node yield in thyroid cancer surgery: a randomized clinical trial. Am J Cancer Res, 2022, 12(9): 4439-4447.
|
33. |
郑传铭, 徐加杰, 王佳峰, 等. 无充气腋窝入路腔镜甲状腺手术的进展与展望. 中国普外基础与临床杂志, 2021, 28(10): 1266-1269.
|
34. |
Ding Y, Qiu C, Zhu C, et al. Comparison of gasless transaxillary endoscopic thyroidectomy, endoscopic thyroidectomy via areola approach and conventional open thyroidectomy in patients with unilateral papillary thyroid carcinoma. World J Surg Oncol, 2024, 22(1): 148. doi: 10.1186/s12957-024-03433-2.
|
35. |
Fassas S, Mamidi I, Lee R, et al. Postoperative complications after thyroidectomy: time course and incidence before discharge. J Surg Res, 2021, 260: 210-219.
|
36. |
Van Uytfanghe K, Ehrenkranz J, Halsall D, et al. Thyroid stimulating hormone and thyroid hormones (Triiodothyronine and Thyroxine): An American Thyroid Association—Commissioned review of current clinical and laboratory status. Thyroid, 2023, 33(9): 1013-1028.
|
37. |
Zou M, Baitei EY, Al-Rijjal RA, et al. TSH overcomes BrafV600E-induced senescence to promote tumor progression via downregulation of p53 expression in papillary thyroid cancer. Oncogene, 2016, 35(15): 1909-1918.
|
38. |
Haymart MR, Glinberg SL, Liu J, et al. Higher serum TSH in thyroid cancer patients occurs independent of age and correlates with extrathyroidal extension. Clin Endocrinol (Oxf), 2009, 71(3): 434-439.
|
39. |
Giovanella L, Ceriani L, Suriano S, et al. Thyroglobulin measurement before rhTSH-aided 131I ablation in detecting metastases from differentiated thyroid carcinoma. Clin Endocrinol (Oxf), 2008, 69(4): 659-663.
|
40. |
Hsieh CJ, Wang PW. Sequential changes of serum antithyroglobulin antibody levels are a good predictor of disease activity in thyroglobulin-negative patients with papillary thyroid carcinoma. Thyroid, 2014, 24(3): 488-493.
|